1 min listen
Vorinostat and bevacizumab for recurrent glioblastoma
Vorinostat and bevacizumab for recurrent glioblastoma
ratings:
Length:
33 minutes
Released:
Jan 1, 2021
Format:
Podcast episode
Description
Dr. Iyad Alnahhas interviews Drs. Vinay Puduvalli and Ying Yuan about their paper "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma" published in Neuro-Oncology in March 2020
Released:
Jan 1, 2021
Format:
Podcast episode
Titles in the series (79)
Announcing Neuro-Oncology: The Podcast: Announcing Neuro-Oncology: The Podcast by Neuro-Oncology: The Podcast